When speaking with your GP, it may be helpful to discuss: Your current BMI and any weight-related health conditions Whether you meet the criteria for existing licensed weight management medications Your reproductive health status, contraception, and any plans for pregnancy Any personal or family history of thyroid disease, pancreatitis, or gallbladder problems Your interest in clinical trials, should you wish to explore participation in retatrutide research Staying informed about emerging treatments is entirely reasonable, but it is important to do so through reliable sources such as the NHS website (nhs.uk), NICE (nice.org.uk), and the MHRA (gov.uk/mhra)
Outcomes 16 , e009078 (2023)
Potential risks include: Overdosing, which can result in severe nausea, vomiting, or hypoglycemia
Hims & Hers CEO Andrew Dudum told CNBC that the company is confident that customers will be able to access a consistent supply of the compounded medications